Improving uptake of screening for colorectal cancer: A study on invitation strategies and different test kit use

European Journal of Gastroenterology and Hepatology

Volumn 27, Issue 5, 2015, Pages 536-543

  Santare, Daiga ^a   Kojalo, Ilona ^a   Huttunen, Teppo ^e   Rikacovs, Sergejs ^b   Rucevskis, Peteris ^b   Boka, Viesturs ^a,c   Leja, Marcis ^a,c,d  

^a UNIVERSITY OF LATVIA   (Latvia)

^b UNIVERSITY OF LATVIA   (Latvia)

^c RIGA EAST UNIVERSITY HOSPITAL   (Latvia)

^d Digestive Diseases Centre GASTRO   (Latvia)

^e Pharma Ltd   (Finland)

Author keywords

Advance notification letter; Colorectal cancer screening; Faecal immunochemical test; Faecal occult blood test; Uptake

Indexed keywords

GUAIAC;

ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; INTERMETHOD COMPARISON; LATVIA; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; PRIORITY JOURNAL; URBAN AREA; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; IMMUNOCHEMISTRY; MIDDLE AGED; PATIENT ATTITUDE; POSTAL MAIL; RANDOMIZATION; REMINDER SYSTEM; SPECIMEN HANDLING; STANDARDS; STATISTICS AND NUMERICAL DATA; UTILIZATION; WRITING;

AGED; COLORECTAL NEOPLASMS; CORRESPONDENCE AS TOPIC; EARLY DETECTION OF CANCER; FEMALE; GUAIAC; HUMANS; IMMUNOCHEMISTRY; LATVIA; MALE; MIDDLE AGED; OCCULT BLOOD; PATIENT ACCEPTANCE OF HEALTH CARE; POSTAL SERVICE; RANDOM ALLOCATION; REMINDER SYSTEMS; SPECIMEN HANDLING;

EID: 84927166603     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000314     Document Type: Article

References (37)

1. Lynge E. Recommendations on cancer screening in the European union. Advisory Committee on Cancer Prevention. Eur J Cancer 2000; 36:1473-1478.
2. Valsts organize¯tais ve¯ža skri¯nings. 37.pielikums MK 2006.gada 19. decembra noteikumiem Nr.1046. 2010. (State Organized Cancer Screening. The Cabinet of Ministers of the Republic of Latvia. The Supplement No. 37 to the Regulations 1046.).
3. Seifert B, Zavoral M, Fric P, Bencko V. The role of primary care in colorectal cancer screening: experience from Czech Republic. Neoplasma 2008; 55:74-80.
4. National Health Service, Latvia: Veža savlaicigas atklašanas programmas rezultati. (Results of the National screening program). Available at: http://www.vmnvd.gov.lv/lv/469-veselibas-aprupes-pakalpojumi/veza-savlaicigas-atklasanas-programma/626-veza-savlaicigas-atklasanas-programmas-rezultati [Accessed 2 December 2013].
5. Segnan N, Patnick J, von Karsa L. European guidelines for quality assurance in colorectal cancer screening and diagnosis. Luxembourg: Office for Official Publications of the European Communities; 2010. Available at: http://bookshop.europa.eu/is-bin/INTERSHOP.enfinity/WFS/EU-Bookshop-Site/en-GB/-/EUR/ViewPublication-Start?PublicationKey=ND3210390. [Accessed 17 February 2012].
6. Council of the European Union. Council Recommendation of 2 December 2003 on cancer screening. Official Journal L 327 of 16.12.2003.
7. Hewitson P, Glasziou P, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev 2007; CD001216.
8. Kerr J, Day P, Broadstock M, Weir R, Bidwell S. Systematic review of the effectiveness of population screening for colorectal cancer. N Z Med J 2007; 120:U2629.
9. Lindholm E, Brevinge H, Haglind E. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg 2008; 95:1029-1036.
10. Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 2007; 99:1462-1470.
11. Van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008; 135:82-90.
12. Wong BC, Wong WM, Cheung KL, Tong TS, Rozen P, Young GP, et al. A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population. Aliment Pharmacol Ther 2003; 18:941-946.
13. Dancourt V, Lejeune C, Lepage C, Gailliard MC, Meny B, Faivre J. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms. Eur J Cancer 2008; 44:2254-2258.
14. Cole SR, Young GP, Esterman A, Cadd B, Morcom J. A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen 2003; 10:117-122.
15. Federici A, Giorgi Rossi P, Borgia P, Bartolozzi F, Farchi S, Gausticchi G. The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial. J Med Screen 2005; 12:83-88.
16. Grazzini G, Visioli CB, Zorzi M, Ciatto S, Banovich F, Bonanomi AG, et al. Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? Br J Cancer 2009; 100:259-265.
17. Krestyaninova M, Zarins A, Viksna J, Kurbatova N, Rucevskis P, Neogi SG, et al. A System for Information Management in BioMedical Studies - SIMBioMS. Bioinformatics 2009; 25:2768-2769.
18. Church TR, Yeazel MW, Jones RM, Kochevar LK, Watt GD, Mongin SJ, et al. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. J Natl Cancer Inst 2004; 96:770-780.
19. Van Roosbroeck S, Hoeck S, Van Hal G. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: A comparison of two invitation strategies. Cancer Epidemiol 2012; 36:e317-e324.
20. Logan RF, Patnick J, Nickerson C, Coleman L, Rutter MD, von Wagner C, et al. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests. Gut 2012; 61:1439-1446.
21. Martini A, Javanparast S, Ward PR, Baratiny G, Gill T, Cole S, et al. Colorectal cancer screening in rural and remote areas: analysis of the National Bowel Cancer Screening Program data for South Australia. Rural Remote Health 2011; 11:1648.
22. Levi Z, Birkenfeld S, Vilkin A, Bar-Chana M, Lifshitz I, Chared M, et al. A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study. Int J Cancer 2011; 128:2415-2424.
23. Digby J, McDonald PJ, Strachan JA, Libby G, Steele RJ, Fraser CG. Use of a faecal immunochemical test narrows current gaps in uptake for sex, age and deprivation in a bowel cancer screening programme. J Med Screen 2013; 20:80-85.
24. Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JC, et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010; 59:62-68.
25. Chubak J, Bogart A, Fuller S, Laing SS, Green BB. Uptake and positive predictive value of fecal occult blood tests: a randomized controlled trial. Prev Med 2013; 57:671-678.
26. Pignone M, Campbell MK, Carr C, Phillips C. Meta-analysis of dietary restriction during fecal occult blood testing. Eff Clin Pract 2001; 4:150-156.
27. Cole SR, Young GP. Effect of dietary restriction on participation in faecal occult blood test screening for colorectal cancer. Med J Aust 2001; 175:195-198.
28. Federici A, Giorgi Rossi P, Bartolozzi F, Farchi S, Borgia P, Guasticchi G. Survey on colorectal cancer screening knowledge, attitudes, and practices of general practice physicians in Lazio, Italy. Prev Med 2005; 41:30-35.
29. Camilloni L, Ferroni E, Cendales BJ, Pezzarossi A, Furnari G, Borgia P, et al. Methods to increase participation in organised screening programs: a systematic review. BMC Public Health 2013; 13:464.
30. Cole SR, Smith A, Wilson C, Turnbull D, Esterman A, Young GP. An advance notification letter increases participation in colorectal cancer screening. J Med Screen 2007; 14:73-75.
31. Libby G, Bray J, Champion J, Brownlee LA, Birrell J, Gorman DR, et al. Pre-notification increases uptake of colorectal cancer screening in all demographic groups: a randomized controlled trial. J Med Screen 2011; 18:24-29.
32. van Roon AH, Hol L, Wilschut JA, Reijerink JC, van Vuuren AJ, van Ballegooijen M, et al. Advance notification letters increase adherence in colorectal cancer screening: a population-based randomized trial. Prev Med 2011; 52:448-451.
33. Stone EG, Morton SC, Hulscher ME, Maglione MA, Roth EA, Grimshaw JM, et al. Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Ann Intern Med 2002; 136:641-651.
34. Sequist TD, Zaslavsky AM, Marshall R, Fletcher RH, Ayanian JZ. Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial. Arch Intern Med 2009; 169:364-371.
35. Lee JK, Groessl EJ, Ganiats TG, Ho SB. Cost-effectiveness of a mailed educational reminder to increase colorectal cancer screening. BMC Gastroenterol 2011; 11:93.
36. Sequist TD, Franz C, Ayanian JZ. Cost-effectiveness of patient mailings to promote colorectal cancer screening. Med Care 2010; 48:553-557.
37. Lamph SA, Bennitt WE, Brannon CR, Halloran SP. Evaluation report: Immunochemical faecal occult blood tests. Reading, UK: NHS Purchasing and Supply Agency; 2009. Available at: http://www.cancerscreening.nhs.uk/bowel/ifobt.pdf [Accessed 20 February 2012].